secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2022-06-06T23:59:59+00:00
Accession:  0001193125-22-168329
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences receives Nasdaq deficiency notice for bid price below $1.00
-----------------------------------------------------------------------------

- Received deficiency letter on May 31, 2022 for failing to meet $1.00 minimum bid price requirement over 30 consecutive business days.
- Company has 180 calendar days, until November 28, 2022, to regain compliance by closing at $1.00 or more for 10 consecutive days.
- If not compliant by November 28, may transfer to Nasdaq Capital Market or consider a reverse stock split to cure deficiency.
- There can be no assurance that the Company will be able to regain compliance with the Bid Price Requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522168329/0001193125-22-168329-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522168329/d316587d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-168329

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer